(Q36565844)

15 August 2017

0 references

Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis (English)

1 reference

15 August 2017

0 references

1 reference

1 reference

Young Ho Lee

1

1 reference

15 August 2017

Young Hee Rho

2

1 reference

15 August 2017

Seong Jae Choi

3

1 reference

15 August 2017

Jong Dae Ji

4

1 reference

15 August 2017

Gwan Gyu Song

5

1 reference

15 August 2017

publication date

15 August 2006

1 reference

Rheumatology International

15 August 2017

published in

1 reference

15 August 2017

volume

27

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

157-161

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-006-0175-7

15 August 2017

exact match

0 references

cites work

Meta-analysis: principles and procedures

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-006-0175-7

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

12 December 2020

The influence of a polymorphism at position -857 of the tumour necrosis factor gene on clinical response to etanercept therapy in rheumatoid arthritis

1 reference

12 December 2020

Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans

1 reference

12 December 2020

Role of cytokines in rheumatoid arthritis

1 reference

12 December 2020

Polymorphism of the human TNF-alpha promoter--random variation or functional diversity?

1 reference

12 December 2020

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

12 December 2020

Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis.

1 reference

12 December 2020

The pathophysiology of tumor necrosis factors

1 reference

12 December 2020

TNF alpha--a pivotal role in rheumatoid arthritis?

1 reference

12 December 2020

Meta-analyses of randomised controlled trials

1 reference

12 December 2020

Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease

1 reference

12 December 2020

Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis

1 reference

12 December 2020

Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis

1 reference

12 December 2020

Investigation of the prognostic value of TNF-alpha gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-alpha production and apoptosis

1 reference

12 December 2020

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes

1 reference

12 December 2020

Polymorphism at position -308 of the tumour necrosis factor alpha gene and rheumatoid arthritis pharmacogenetics.

1 reference

12 December 2020

Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?

1 reference

12 December 2020

10.1007/S00296-006-0175-7

Identifiers

DOI

1 reference

15 August 2017

1 reference